Biological composition for use as a reference control in diagnostic analysis

• US 3,876,375 A
• Filed: 08/20/1973
• Issued: 04/08/1975
• Est. Priority Date: 11/22/1971
• Status: Expired due to Term

• Current Assignee: Jonas Maurukas
• Original Assignee: Jonas Maurukas
• Inventors: Maurukas, Jonas
• Primary Examiner(s): Serwin, R. E.
• Application Number:
  US05/389,870
• Time in Patent Office: 596 Days
• Field of Search: 23/23B 252/408 424/101
• US Class Current: 436/16
• CPC Class Codes: G01N 2496/05 containing blood cells or plasma
• CPC Class Codes: G01N 2496/80 Multi-analyte reference solutions containing cholesterol, glucose and the like
• CPC Class Codes: G01N 33/96 involving blood or serum control standard
• CPC Class Codes: Y10T 436/103332 Bilirubin or uric acid standard or control
• CPC Class Codes: Y10T 436/104165 Lipid, cholesterol, or triglyceride standard or control
• CPC Class Codes: Y10T 436/104998 Glucose, ketone, nitrate standard or control
• CPC Class Codes: Y10T 436/105831 Protein or peptide standard or control [e.g., hemoglobin, etc.]
• CPC Class Codes: Y10T 436/106664 Blood serum or blood plasma standard or control
• CPC Class Codes: Y10T 436/108331 Preservative, buffer, anticoagulant or diluent
• CPC Class Codes: Y10T 436/109163 Inorganic standards or controls

Abstract

Preparation of stable aqueous-containing biological compositions capable of use as liquid human reference serums in diagnostic analysis using sequential multichannel automated analyzers having improved storage stability and capable of storage in the liquid state for extended periods of time at temperatures ranging from about -20.degree.C. to ambient room temperatures, processes for preparing the reference serums and the process of automated analysis utilizing the improved reference serums. The subject materials are prepared by freezing the aqueous-containing labile biologicals rapidly at temperatures ranging from about 20.degree. to about -30.degree.C., removing from 20 to 40 weight per cent of the water therefrom, adding to the partially dewatered material alkylene polyol containing from 2 to 5 carbon atoms in a concentration substantially the same as the removed water, mixing the components and reducing the freezing temperature thereof to a temperature of about -20.degree. to 25.degree.C. followed by the storage in the liquid state preferably at from -20.degree. to 0.degree.C.

Claims

1. A STABLE, LIQUID BIOLOGICAL REFERENCE CONTROL COMPOSITION FOR USE IN ANALYSIS OF BIOLOGICALLY SIMILAR UNKNOWNS, SAID COMPOSITION BEING STABLE AT -20*C. AND CAPABLE OF EXTENDED STORAGE IN THE LIQUID STATE AT SAID TEMPERATURE AND COMPRISING IN ITS NON-BIOLOGICAL COMPONENT FROM ABOUT 60 TO ABOUT 80 WEIGHT PER CENT WATER, FROM ABOUT 20 TO ABOUT 40 WEIGHT PER CENT OF AT LEAST ONE ALKYLENE POLYOL HAVING FROM 2 TO 5 CARBON ATOMS, THE REMAINDER BEING CHIEFLY AT LEAST ONE NATURAL BIOLOGICAL MATERIAL SELECTED FROM THE GROUP CONSISTING OF BLOOD SERUM, ENZYME, METABOLITES, ELECTROLYTES AND HORMONES.

2. A composition as in claim 1 wherein said biological material is human blood serum.

3. A composition as in claim 1 wherein said alkylene polyol is ethylene glycol.

4. A composition as in claim 1 wherein said alkylene polyol is propylene glycol.

5. A composition as in claim 1 wherein said alkylene polyol is butylene glycol.

6. A composition as in claim 1 wherein said alkylene polyol is pentanediol.

7. A composition as in claim 1 wherein said alkylene polyol is glycerol.

8. A process for preparing stable, liquid, biological reference control compositions for use in analysis of naturally occurring biologically similar unknowns, said compositions being stable at -20.degree.C. and capable of extended storage in the liquid stage at said temperature comprising A. obtaining a portion of biological materials similar in composition to and containing the same component materials as the unknown to be analyzed, B. freezing said biological material over a period of about 10 to about 24 hours, C. removing from about 20 to about 40 per cent water therefrom, D. adding at least one alkylene polyol containing from about 2 to about 5 carbon atoms thereto in a concentration substantially the same as the removed water, E. mixing the components thereof, and F. reducing the freezing temperature thereof to from about 0.degree.C. to about -20.degree.C.

9. A process as in claim 8 wherein the temperature thereof is reduced in step (F) to a temperature of about -20.degree.C.

10. A process as in claim 8 wherein from about 25 to about 35 weight per cent water is removed in step (C).

11. A process as in claim 8 wherein said alkylene polyol is ethylene glycol.

12. A process as in claim 8 wherein said alkylene polyol is propylene glycol.

13. A process as in claim 8 wherein said alkylene polyol is glycerol.

14. A process as in claim 8 wherein said alkylene polyol is butylene glycol.

15. A process as in claim 8 wherein said alkylene polyol is pentane diol.

16. A process as in claim 8 wherein said biologically similar material is human blood serum.

17. A process as in claim 8 wherein the removal of water is conducted while said biologically similar material is frozen at reduced pressures ranging from about 1 to about 10 millimeters of mercury.

18. A process as in claim 17 wherein said reduced pressure ranges from about 5 to about 10 millimeters of mercury.

19. A process as in claim 8 wherein removal of water is conducted by slowly and gradually raising the temperature of said frozen biologically similar material from a temperature of about -20.degree. to about 0.degree.C. over a period ranging from about 10 to about 30 hours.

20. A process as in claim 19 wherein said temperature is aobut 0.degree.C. and said time period ranges from about 10 to about 24 hours.

21. IN A PROCESS FOR PERFORMING AUTOMATED CONTINUOUS FLOW MULTICHANNEL ANALYSES OF UNKNOWN BIOLOGICALLY ACTIVE NATURALLY OCCURRING MATERIALS, THE IMPROVEMENT WHICH COMPRISES EMPLOYING THE STABLE LIQUID COMPOSITION OF CLAIM 1 AS A REFERENCE CONTROL IN STANDARDIZING THE AUTOMATED ANALYZER AND THEREAFTER CONDUCTING CONTINUOUS FLOW MULTICHANNEL ANALYSES UTILIZING SAID REFERENCE CONTROL COMPOSITION WHEREIN SAID REFERENCE CONTROL COMPOSITION CONTAINS THE SAME COMPONENT MATERIALS AS SAID UNKNOWNS.

22. In a process for performing automated continuous flow multichannel analysis on unknown biologically active human blood serum, the improvement which comprises employing the stable liquid composition of claim 2 as a reference control in standardizing the automated analyzer and thereafter conducting continuous flow multichannel analyses on human blood serum unknowns containing the same component materials as said reference control composition.